Document is current
Any future updates will be listed below
-
Authors
Negrón, José B. https://orcid.org/0000-0003-4659-5508
Lopez-Olivo, Maria A. https://orcid.org/0000-0002-5165-8393
Carmona, Loreto https://orcid.org/0000-0002-4401-2551
Christensen, Robin https://orcid.org/0000-0002-6600-0631
Ingegnoli, Francesca https://orcid.org/0000-0002-6727-1273
Zamora, Natalia V. https://orcid.org/0000-0002-3785-4662
Gonzalez-Lopez, Laura https://orcid.org/0000-0002-6517-6344
Strand, Vibeke https://orcid.org/0000-0003-4978-4072
Goel, Niti https://orcid.org/0000-0001-5869-5157
Westrich-Robertson, Tiffany
Suarez-Almazor, Maria E. https://orcid.org/0000-0001-5381-5797
- License Information
-
More Information
Article History
Received: 14 May 2025
Accepted: 23 July 2025
First Online: 8 August 2025
Declarations
:
: No funding was received for the completion of this research study. However, JBN has received personal grants from the European Alliance of Associations for Rheumatology (EULAR) for activities unrelated to this work. Additionally, JBN held the position of OMERACT fellow in the POLOS in RA Working Group during the data collection period. VS is a founder of OMERACT, an organization that develops and validates outcome measures in rheumatology randomized controlled trials and longitudinal observational studies.
